source
- Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, which could make the sector more broadly appealing to investors, some say.BioPharma Dive · 4mo ago↗ source
- Novartis CEO disheartened by Germany’s planned €60B cuts to healthcare spendingNovartis CEO Vas Narasimhan said the Swiss company is “very disappointed” by Germany’s plan to shave off more than €60 billion in healthcare costs that would affect pharma sales. Germany wants to s…Endpoints · 4mo ago↗ source
- Opinion: Why do discussions about ‘brain health’ ignore mental illness?“Failing to adopt a more inclusive concept of brain health represents a massive loss of human potential,” write Husseini K. Manji, Eric J. Nestler, and Patrick J. Kennedy.